AIMC Topic: Drug-Related Side Effects and Adverse Reactions

Clear Filters Showing 311 to 320 of 343 articles

Drug knowledge bases and their applications in biomedical informatics research.

Briefings in bioinformatics
Recent advances in biomedical research have generated a large volume of drug-related data. To effectively handle this flood of data, many initiatives have been taken to help researchers make good use of them. As the results of these initiatives, many...

An investigation of single-domain and multidomain medication and adverse drug event relation extraction from electronic health record notes using advanced deep learning models.

Journal of the American Medical Informatics Association : JAMIA
OBJECTIVE: We aim to evaluate the effectiveness of advanced deep learning models (eg, capsule network [CapNet], adversarial training [ADV]) for single-domain and multidomain relation extraction from electronic health record (EHR) notes.

Reply to comment on: "Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts".

Journal of the American Medical Informatics Association : JAMIA
We appreciate the detailed review provided by Magge et al1 of our article, "Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts." 2 In their letter, they present a subjectiv...

A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding.

Drug safety
INTRODUCTION: Adverse drug reaction (ADR) detection in hospitals is heavily reliant on spontaneous reporting by clinical staff, with studies in the literature pointing to high rates of underreporting [1]. International Classification of Diseases, 10t...

Artificial Intelligence Within Pharmacovigilance: A Means to Identify Cognitive Services and the Framework for Their Validation.

Pharmaceutical medicine
INTRODUCTION: Pharmacovigilance (PV) detects, assesses, and prevents adverse events (AEs) and other drug-related problems by collecting, evaluating, and acting upon AEs. The volume of individual case safety reports (ICSRs) increases yearly, but it is...

Artificial Intelligence and the Future of the Drug Safety Professional.

Drug safety
The healthcare industry, and specifically the pharmacovigilance industry, recognizes the need to support the increasing amount of data received from individual case safety reports (ICSRs). To cope with this increase, more healthcare and qualified pro...

Facilitating prediction of adverse drug reactions by using knowledge graphs and multi-label learning models.

Briefings in bioinformatics
Timely identification of adverse drug reactions (ADRs) is highly important in the domains of public health and pharmacology. Early discovery of potential ADRs can limit their effect on patient lives and also make drug development pipelines more robus...

Adverse Drug Events Detection in Clinical Notes by Jointly Modeling Entities and Relations Using Neural Networks.

Drug safety
BACKGROUND AND SIGNIFICANCE: Adverse drug events (ADEs) occur in approximately 2-5% of hospitalized patients, often resulting in poor outcomes or even death. Extraction of ADEs from clinical narratives can accelerate and automate pharmacovigilance. U...

Detecting Adverse Drug Events with Rapidly Trained Classification Models.

Drug safety
INTRODUCTION: Identifying occurrences of medication side effects and adverse drug events (ADEs) is an important and challenging task because they are frequently only mentioned in clinical narrative and are not formally reported.